Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01185574 · ClinicalTrials.gov registry record · NA

Vitamin D for Improving Metabolic Control and Depressive Symptoms

A NA study of Diabetes and Depressive Symptoms, sponsored by Loyola University.

Completed
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT01185574: Completed NA study of Diabetes and Depressive Symptoms, sponsored by Loyola University.

NCT01185574 is a NA study of Diabetes and Depressive Symptoms that has completed, run by Loyola University. The registered enrollment target is 50 participants, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01185574, a NA study of Diabetes and Depressive Symptoms, has completed, sponsored by Loyola University.

COMPLETED
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

This study will examine whether weekly vitamin D supplementation in women with significant depressive symptoms and diabetes will exhibit improved mood and metabolic control. If supplementation with Vitamin D is beneficial, it will be a simple and cost-effective method for treatment. Women will be targeted since they have greater depression and worse metabolic control than men with diabetes.

Interventions

  • DIETARY_SUPPLEMENT Vitamin D supplementation

Study Locations (1)

Illinois

  • Loyola University Medical Center - Maywood

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2009-10
Est. Completion 2012-05
Phase NA
Loyola University

92 total trials

What the finished NCT01185574 record still lists

NCT01185574 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (98% lower).

The record links to 2 conditions, with Diabetes appearing as the primary indexed condition, and to 1 intervention - of which Vitamin D supplementation is the first listed.

NCT01185574 reports a single indexed study location in Illinois.

Frequently Asked Questions

What is clinical trial NCT01185574 about?

NCT01185574 is a clinical study titled "Vitamin D for Improving Metabolic Control and Depressive Symptoms". This study will examine whether weekly vitamin D supplementation in women with significant depressive symptoms and diabetes will exhibit improved mood and metabolic control. If supplementation with Vitamin D is beneficial, it will be a simple and cost-effective method for treatment. Women will be ta...

What is the current status of trial NCT01185574?

This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2009-10. Estimated completion is 2012-05.

What conditions does trial NCT01185574 study?

This clinical trial studies the following conditions: Diabetes, Depressive Symptoms.

What interventions are being tested in trial NCT01185574?

The interventions under investigation include: Vitamin D supplementation (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT01185574?

This trial is sponsored by Loyola University, which has 92 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01185574 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01185574's enrollment target sits among peer trials

50 249th of 338 higher than 85 of 338 other Diabetes trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Diabetes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00200889 · 50 participants · Early Phase 1

    Mapping Auricular Vagus Nerve Circuitry

  • NCT00409435 · 50 participants · Phase 2

    A Study of Pyridostigmine in Postural Tachycardia Syndrome

  • NCT01202305 · 50 participants

    The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies

  • NCT01225913 · 50 participants · Phase 4

    Mechanism(s) of Airflow Limitation During Exacerbation of Asthma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01185574, the US trial registry maintained by the National Library of Medicine. NCT01185574 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.